University of Alabama At Birmingham Comprehensive Cancer Center — Birmingham, Alabama

University of Alabama At Birmingham Comprehensive Cancer Center is a clinical research site located in Birmingham, Alabama, United States 35205.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Alabama At Birmingham Comprehensive Cancer Center has participated in 5 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma, Lymphoma.

Sponsors: Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama At Birmingham Comprehensive Cancer Center?

University of Alabama At Birmingham Comprehensive Cancer Center has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama At Birmingham Comprehensive Cancer Center conducted?

University of Alabama At Birmingham Comprehensive Cancer Center has 5 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma, Lymphoma.

Is University of Alabama At Birmingham Comprehensive Cancer Center accredited by Crixeo Health?

University of Alabama At Birmingham Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama At Birmingham Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.